XT
TENX icon

XTX Topco’s Tenax Therapeutics TENX Stock Holding History

XTX Topco’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$765K Buy
+47,851
New +$647K 0.01% 1652
2024
Q1 		– Sell
-532
Closed -$11.7K – 2310
2023
Q4 		$11.7K Buy
+532
New +$12.8K ﹤0.01% 1415

Other funds holding TENX

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCIM
Velan Capital Investment Management Alpharetta, Georgia $160M AUM 517.12% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

XTX Topco's TENX Position: Q1 2026 in Review

XTX Topco opened a new position in Tenax Therapeutics (TENX) in Q1 2026: 47,851 shares worth $765K. The stake represents 0.01% of the portfolio and ranks #1652 among its holdings. This is a return to the name: XTX Topco previously reported a position in TENX as recently as Q4 2023.

XTX Topco first reported a position in TENX in Q4 2023 and has held it in 2 quarters since. 80 funds tracked by Wall St. Rank hold TENX as of Q1 2026.

  • XTX Topco held 47,851 shares of Tenax Therapeutics worth $765K as of Q1 2026.
  • Tenax Therapeutics was a new XTX Topco position in Q1 2026.
  • Tenax Therapeutics made up 0.01% of XTX Topco's portfolio in Q1 2026, its #1652 holding.
  • XTX Topco first reported a position in Tenax Therapeutics in Q4 2023 and has held it in 2 quarters since.
  • 80 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.